Evaluation of tumoral enhancement by superparamagnetic iron oxide particles:: comparative studies with ferumoxtran and anionic iron oxide nanoparticles

被引:22
作者
Brillet, PY [1 ]
Gazeau, F [1 ]
Luciani, A [1 ]
Bessoud, B [1 ]
Cuénod, CA [1 ]
Siauve, N [1 ]
Pons, JN [1 ]
Poupon, J [1 ]
Clément, O [1 ]
机构
[1] Hop Avicenne, Dept Radiol, F-93009 Bobigny, France
关键词
iron oxide nanoparticles; relaxometry; magnetic resonance imaging; cell magnetic labeling; tumor targeting;
D O I
10.1007/s00330-004-2586-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This study was designed to compare tumor enhancement by superparamagnetic iron oxide particles, using anionic iron oxide nanoparticles (AP) and ferumoxtran. In vitro, relaxometry and media with increasing complexity were used to assess the changes in r2 relaxivity due to cellular internalization. In vivo, 26 mice with subcutaneously implanted tumors were imaged for 24 h after injection of particles to describe kinetics of enhancement using T1 spin echo, T2 spin echo, and T2 fast spin echo sequences. In vitro, the r2 relaxivity decreased over time (0-4 h) when AP were uptaken by cells. The loss of r2 relaxivity was less pronounced with long (Hahn Echo) than short (Carr-Purcell-Meiboom-Gill) echo time sequences. In vivo, our results with ferumoxtran showed an early T2 peak (1 h), suggesting intravascular particles and a second peak in T1 (12 h), suggesting intrainterstitial accumulation of particles. With AP, the late peak (24 h) suggested an intracellular accumulation of particles. In vitro, anionic iron oxide nanoparticles are suitable for cellular labeling due to a high cellular uptake. Conversely, in vivo, ferumoxtran is suitable for passive targeting of tumors due to a favorable biodistribution.
引用
收藏
页码:1369 / 1377
页数:9
相关论文
共 38 条
[1]   Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography [J].
Adonai, N ;
Nguyen, KN ;
Walsh, J ;
Iyer, M ;
Toyokuni, T ;
Phelps, ME ;
McCarthy, T ;
McCarthy, DW ;
Gambhir, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3030-3035
[2]   Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - Initial clinical experience [J].
Bellin, MF ;
Roy, C ;
Kinkel, K ;
Thoumas, D ;
Zaim, S ;
Vanel, D ;
Tuchmann, C ;
Richard, F ;
Jacqmin, D ;
Delcourt, A ;
Challier, E ;
Lebret, T ;
Cluzel, P .
RADIOLOGY, 1998, 207 (03) :799-808
[3]   BIODISTRIBUTION OF AN ULTRASMALL SUPERPARAMAGNETIC IRON-OXIDE COLLOID, BMS-180549, BY DIFFERENT ROUTES OF ADMINISTRATION [J].
BENGELE, HH ;
PALMACCI, S ;
ROGERS, J ;
JUNG, CW ;
CRENSHAW, J ;
JOSEPHSON, L .
MAGNETIC RESONANCE IMAGING, 1994, 12 (03) :433-442
[4]   Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging [J].
Billotey, C ;
Wilhelm, C ;
Devaud, M ;
Bacri, JC ;
Bittoun, J ;
Gazeau, F .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (04) :646-654
[5]  
Bjerner T, 2000, J MAGN RESON IMAGING, V12, P866, DOI 10.1002/1522-2586(200012)12:6<866::AID-JMRI9>3.0.CO
[6]  
2-Q
[7]  
BRILLET PY, 2003, EUR RADIOL, V13, P439
[8]   FREQUENCY-DEPENDENCE OF MR RELAXATION-TIMES .2. IRON-OXIDES [J].
BULTE, JWM ;
VYMAZAL, J ;
BROOKS, RA ;
PIERPAOLI, C ;
FRANK, JA .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 1993, 3 (04) :641-648
[9]   Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination [J].
Bulte, JWM ;
Zhang, SC ;
van Gelderen, P ;
Herynek, V ;
Jordan, EK ;
Duncan, ID ;
Frank, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15256-15261
[10]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845